XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 25, 2022   34,736          
Beginning balance at Dec. 25, 2022 $ (270,664) $ 491 $ 449,829 $ (10,135) [1] $ 195,856 $ (922,434) [2] $ 15,729
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [3] 40,300       40,144   156
Other comprehensive income (loss), net of tax 2,846     2,846 [1]      
Dividends on common stock (28,485)   54   (28,539)    
Exercise of stock options (in shares)   17          
Exercise of stock options $ 683 $ 1 682        
Acquisition of Company common stock (in shares) (2,523) (2,523)          
Acquisition of Company common stock $ (212,444)         (212,444) [2]  
Stock-based compensation expense 8,498   8,498        
Issuance of restricted stock (in shares)   227          
Issuance of restricted stock 0   (6,542)     6,542 [2]  
Tax effect of restricted stock awards (in shares)   (73)          
Tax effect of restricted stock awards (6,108)   (6,108)        
Distributions to noncontrolling interests (323)           (323)
Other (in shares)   10          
Other 218   (449)     667 [2]  
Ending balance (in shares) at Jun. 25, 2023   32,394          
Ending balance at Jun. 25, 2023 (465,479) $ 492 445,964 (7,289) [1] 207,461 (1,127,669) [2] 15,562
Beginning balance (in shares) at Mar. 26, 2023   32,356          
Beginning balance at Mar. 26, 2023 (475,325) $ 492 443,686 (8,766) [1] 203,569 (1,130,136) [2] 15,830
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [3] 17,800       17,768   32
Other comprehensive income (loss), net of tax 1,477     1,477 [1]      
Dividends on common stock (13,822)   54   (13,876)    
Exercise of stock options (in shares)   2          
Exercise of stock options $ 68   68        
Acquisition of Company common stock (in shares) 0            
Stock-based compensation expense $ 4,601   4,601        
Issuance of restricted stock (in shares)   30          
Issuance of restricted stock 0   (1,933)     1,933 [2]  
Tax effect of restricted stock awards (in shares)   (1)          
Tax effect of restricted stock awards (109)   (109)        
Distributions to noncontrolling interests (300)           (300)
Other (in shares)   7          
Other 131   (403)     534 [2]  
Ending balance (in shares) at Jun. 25, 2023   32,394          
Ending balance at Jun. 25, 2023 $ (465,479) $ 492 445,964 (7,289) [1] 207,461 (1,127,669) [2] 15,562
Beginning balance (in shares) at Dec. 31, 2023 32,500 32,488          
Beginning balance at Dec. 31, 2023 $ (443,616) $ 492 452,290 (7,803) [4] 219,027 (1,123,098) 15,476
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [5] 27,260       26,879   381
Other comprehensive income (loss), net of tax 445     445 [4]      
Dividends on common stock (30,042)   64   (30,106)    
Exercise of stock options (in shares)   20          
Exercise of stock options $ 933 $ 1 932        
Acquisition of Company common stock (in shares) 0            
Stock-based compensation expense $ 2,545   2,545        
Issuance of restricted stock (in shares)   157          
Issuance of restricted stock 0   (5,610)     5,610  
Tax effect of restricted stock awards (in shares)   (48)          
Tax effect of restricted stock awards (3,330)   (3,330)        
Distributions to noncontrolling interests (339)           (339)
Other (in shares)   5          
Other $ 4   (344)     348  
Ending balance (in shares) at Jun. 30, 2024 32,600 32,622          
Ending balance at Jun. 30, 2024 $ (446,140) $ 493 446,547 (7,358) [4] 215,800 (1,117,140) 15,518
Beginning balance (in shares) at Mar. 31, 2024   32,604          
Beginning balance at Mar. 31, 2024 (446,423) $ 493 444,793 (7,554) [4] 218,608 (1,118,196) 15,433
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [5] 12,445       12,243   202
Other comprehensive income (loss), net of tax 196     196 [4]      
Dividends on common stock (15,019)   32   (15,051)    
Exercise of stock options (in shares)   2          
Exercise of stock options $ 92   92        
Acquisition of Company common stock (in shares) 0            
Stock-based compensation expense $ 2,915   2,915        
Issuance of restricted stock (in shares)   16          
Issuance of restricted stock 0   (900)     900  
Tax effect of restricted stock awards (in shares)   (3)          
Tax effect of restricted stock awards (138)   (138)        
Distributions to noncontrolling interests (117)           (117)
Other (in shares)   3          
Other $ (91)   (247)     156  
Ending balance (in shares) at Jun. 30, 2024 32,600 32,622          
Ending balance at Jun. 30, 2024 $ (446,140) $ 493 $ 446,547 $ (7,358) [4] $ 215,800 $ (1,117,140) $ 15,518
[1] At June 25, 2023, the accumulated other comprehensive loss of $7,289 was comprised of net unrealized foreign currency translation loss of $7,274 and net unrealized loss on the interest rate swap agreements of $15.
[2] Acquisition of Company common stock for the six months ended June 25, 2023, includes $2,804 of transaction costs directly attributable to share repurchases, including a 1% excise tax incurred under the Inflation Reduction Act of 2022.
[3] Net income to the Company for the three and six months ended June 25, 2023 excludes $59 and $105, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.
[4] At June 30, 2024, the accumulated other comprehensive loss of $7,358 was comprised of net unrealized foreign currency translation loss of $7,784 and net unrealized gain on the interest rate swap agreements of $426.
[5] Net income to the Company for the three and six months ended June 30, 2024 excludes $91 and $190, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.